Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance
MarketWatch
🎉ANOTHER BIG EARNINGS WEEK IS UPON US!
💰 $GOOGL $AMZN $AMD $ARM $QCOM $PLTR $SNAP $DIS $PYPL $LLY $PFE $MRK $NVO $UBER $F $RACE $TM $PEP $CMG ARE ALL SET TO DELIVER RESULTS!
📈PLAN EARLY WITH ALL KEY DATA IN 1 PLACE: https://t.co/Zh3sZIRv6K 👈 https://t.co/0Zont0zt9H https://t.co/JTwOtijLxx
@Investingcom
🇺🇸EARNINGS THIS WEEK:
• ALPHABET $GOOGL
• AMAZON $AMZN
• AMD $AMD
• ARM HOLDINGS $ARM
• QUALCOMM $QCOM
• PALANTIR $PLTR
• FORTINET $FTNT
• SNAP $SNAP
• ROBLOX $RBLX
• WALT DISNEY $DIS
• PAYPAL $PYPL
• ELI LILLY $LLY
• PFIZER $PFE
• MERCK $MRK
• NOVO NORDISK $NVO… https://t.co/n8VluKA3Gy https://t.co/NBsP246CAc
@Investingcom
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends Hemophilia pact
MarketWatch
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
MarketWatch
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
MarketWatch
Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
CNBC
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC
CNBC
FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC
CNBC
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
MarketWatch
Pfizer former executives exit activist drive (NYSE:PFE) - Seeking Alpha
Seeking Alpha
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says - CNBC
CNBC
Former Pfizer CEO, finance chief step back from Starboard's activist campaign - CNBC
CNBC
Pfizer wins bid to invalidate GSK's patents over RSV vaccine https://t.co/U4qDo7fLwQ https://t.co/1oT7s25ePe
@Reuters
Activist investor Starboard has informed Pfizer it has taken a stake - Business Insider
Business Insider
Starboard reportedly takes $1 billion stake in Pfizer, seeks changes
MarketWatch
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say - CNBC
CNBC
Activist Starboard takes $1B stake in Pfizer - WSJ
SeekingAlpha
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer - The Wall Street Journal
The Wall Street Journal
Pfizer yanks sickle-cell treatment worldwide after possible link to deaths
MarketWatch
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results - CNBC
CNBC
Pfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccine
MarketWatch
Pfizer-BioNTech’s COVID-19-and-flu combination drug meets 1 of 2 trial objectives
MarketWatch
Pfizer reports positive results in study of vaccine for immunocompromised adults at risk of severe RSV-related illness
Pfizer announces positive results from late-stage trial of hemophilia A treatment
MarketWatch
Pfizer signals progress on obesity pill, boosting stock
MarketWatch
Pfizer moves forward with once-daily version of weight loss pill after setbacks
CNBC
SEC blasts Pfizer's bid for $75 million from insider trading victims' fund https://t.co/zi2o5UQjRt https://t.co/oqYMmcJzfN
@Reuters
Pfizer defends appellate court’s ‘naming names’ rule in lawsuit over diversity program https://t.co/AJ35cUGXng https://t.co/0EpfCJjqze
@Reuters
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case https://t.co/eCV2WLo1sb https://t.co/ant6wAXYMX
@Reuters
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline - CNBC
CNBC
Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster
MarketWatch
Pfizer's Duchenne gene therapy fails in late-stage study https://t.co/z9hCGWBuFv https://t.co/re9Wjf19vK
@Reuters
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds https://t.co/u3wDGUZL8s https://t.co/H7rNkEGC2s
@Reuters
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial https://t.co/1HCc8JsuZy https://t.co/bHfQ2WNCOK
@Reuters
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot https://t.co/pu0pSdZbog https://t.co/gKLeO9j877
@Reuters
⚠️ JUST IN:
*PFIZER SAYS YOUNG BOY WHO GOT GENE THERAPY SUFFERED CARDIAC ARREST
$PFE https://t.co/VXFOAflzIJ
@Investingcom
Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC https://t.co/gRRWscbh4s https://t.co/01D983fx9G
@Reuters
Pfizer reports patient death in Duchenne gene therapy study https://t.co/4qCybBOOSL https://t.co/GfgTr3Dxvm
@Reuters
AI-Driven Drug Discovery by Pfizer and Austrian Institute Set to Transform Healthcare
Cryptopolitan
S&P index error may have sparked turbulence in Morgan Stanley, Pfizer shares, traders say https://t.co/bV5U63lZZW https://t.co/lXrxneO76p
@Reuters
Ex-Pfizer employee convicted of insider trading on COVID drug trial https://t.co/luI3r8Ww4b https://t.co/phN98DFyMs
@Reuters
Former Pfizer employee goes down for insider trading in COVID drug trial
Cryptopolitan
Pfizer closes Seagen acquisition
SeekingAlpha
Pfizer shares fall as 2024 revenue and profit forecast disappoints
CNBC
Seagen gains amid options trades, optimism for FTC approval for Pfizer deal
SeekingAlpha
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops - CNBC
CNBC
⚠️BREAKING:
*PFIZER SHARES TUMBLE 7% AFTER ABANDONING PLANS FOR WEIGHT LOSS PILL
$PFE https://t.co/SrVSxf8PwG
@Investingcom
FAQs
What is Pfizer stock price today?
The current price of Pfizer is 26.27 USD — it has increased by 1.45% in the past 24 hours. Watch Pfizer stock price performance more closely on the advanced chart.
What is Pfizer stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Pfizer stocks are traded under the ticker PFE.
Is PFE stock price going up?
PFE stock has increased by 2.90% in the past week, has decreased by -1.37% in the past month, and has decreased by -5.06% in the past year. See more data on PFE chart.
What is the analyst recommendation for PFE?
As of 22 Feb 2025, out of 13 analyst recommendations, the majority rate PFE as a hold.
What is PFE market cap?
As of today, PFE has the market capitalization of 146.72B USD. Explore our list of stocks ranked by market cap to compare PFE with other stocks.
Does PFE release financial reports?
Yes, you can track PFE financials in yearly and quarterly reports on Profit.com.
When is PFE next earnings date?
PFE is going to release the next earnings report on 29 Apr 2025. Keep track of upcoming events with our Earnings Calendar.
What were PFE Earnings for the last quarter?
PFE reported earnings of $1.06 per share for the last quarter, higher then the estimate of $0.62 per share, resulting in a 70.97% surprise. The estimated earnings for the next quarter are $0.49 per share. See more details about PFE earnings on Profit.com.
What was PFE Revenue for the last quarter?
PFE's revenue for the last quarter was 17.76B USD, higher then the estimated 13.54B USD. The estimated revenue for the next quarter is 15.75B USD See more stats in PFE financial reports on Profit.com.
What was PFE Net Income for the last quarter?
PFE net income for the last quarter is 410M USD, while the quarter before that showed 4.46B USD of net income which accounts for -90.82% change. See more stats in PFE financial reports on Profit.com.
Does PFE pay dividends?
Yes, PFE dividends are paid quarterly. The last dividend per share was 1.68. As of today, Dividend Yield (TTM)% is 6.64%.
How many employees does PFE have?
As of 22 Feb 2025, PFE employs approximately - employees. Check out if PFE is on our list of largest employers.
What is PFE EBITDA?
EBITDA, which measures a company's operating performance, reflects its efficiency improvements. PFE EBITDA is 23.27B USD, with a current EBITDA margin of 12.62%. See more stats in PFE financial reports on Profit.com.
How to buy PFE stocks?
Like other stocks, PFE shares are traded on stock exchanges such as NYSE. The easiest way to buy them is through an online stock broker. Simply open an account, follow the broker's procedures, and start trading. Alternatively, you can practice trading Tesla stock on Profit.com in Playtrade Tournaments or choose a recommended broker to trade directly.
Should I invest in PFE stock?
Investing in stocks requires thorough research, including analyzing the company’s financials, related news, and technical analysis. Currently, Tesla's technical analyst recommendations show a hold rating.